Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 866 entries
View as:

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01413893 Org: User:
Start: 06/30/11 End: 06/30/12 Due: 06/30/13

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02531178 Org: User:
Start: 07/31/15 End: 02/29/16 Due: 02/28/17

Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02296905 Org: User:
Start: 10/31/14 End: 09/30/15 Due: 09/30/16

A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor

Phase: N/A Priority: Normal
NCT ID: NCT05538585 Org: User:
Start: 09/27/22 End: 12/21/22 Due: 12/21/23

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT04949828 Org: User:
Start: 09/16/21 End: 02/29/24 Due: 02/28/25

The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT02581202 Org: User:
Start: 12/21/15 End: 05/27/17 Due: 05/27/18

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Phase: N/A Priority: Normal
NCT ID: NCT07023289 Org: User:
Start: 09/05/25 End: 11/30/29 Due: 11/30/30

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04804254 Org: User:
Start: 04/27/21 End: 01/11/23 Due: 01/11/24

Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically

Phase: N/A Priority: Normal
NCT ID: NCT02808975 Org: User:
Start: 07/18/16 End: 10/16/19 Due: 10/16/20

A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Phase: N/A Priority: Normal
NCT ID: NCT01995071 Org: User:
Start: 11/30/13 End: 06/30/15 Due: 06/30/16

Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02944396 Org: User:
Start: 12/23/16 End: 10/02/19 Due: 10/02/20

A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02486406 Org: User:
Start: 10/28/15 End: 11/19/20 Due: 11/19/21

A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05283681 Org: User:
Start: 04/02/19 End: 11/11/19 Due: 11/11/20

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

Phase: N/A Priority: Normal
NCT ID: NCT03391765 Org: User:
Start: 01/24/18 End: 12/13/19 Due: 12/13/20

A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04437433 Org: User:
Start: 06/18/20 End: 06/11/24 Due: 06/11/25

A Study of SC-007 in Subjects With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03253185 Org: User:
Start: 09/13/17 End: 04/02/18 Due: 04/02/19

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03675308 Org: User:
Start: 03/25/19 End: 09/28/26 Due: 09/28/27

A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02095574 Org: User:
Start: 09/30/14 End: 01/31/15 Due: 01/31/16

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Phase: N/A Priority: Normal
NCT ID: NCT02636608 Org: User:
Start: 11/27/15 End: 05/23/18 Due: 05/23/19

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

Phase: N/A Priority: Normal
NCT ID: NCT02264990 Org: User:
Start: 09/30/14 End: 02/21/20 Due: 02/21/21

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Phase: N/A Priority: Normal
NCT ID: NCT02706951 Org: User:
Start: 03/23/16 End: 08/10/22 Due: 08/10/23

Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)

Phase: N/A Priority: Normal
NCT ID: NCT03779841 Org: User:
Start: 03/01/19 End: 03/06/23 Due: 03/06/24

A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02287233 Org: User:
Start: 12/31/14 End: 08/10/21 Due: 08/10/22

A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs

Phase: N/A Priority: Normal
NCT ID: NCT02706847 Org: User:
Start: 03/15/16 End: 02/08/22 Due: 02/08/23

A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06125795 Org: User:
Start: 11/06/23 End: 07/31/26 Due: 07/31/27